Advertisement

Diabetologia

, Volume 62, Issue 7, pp 1185–1194 | Cite as

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017

  • Donghee Kim
  • Andrew A. Li
  • George Cholankeril
  • Sun H. Kim
  • Erik Ingelsson
  • Joshua W. Knowles
  • Robert A. Harrington
  • Aijaz AhmedEmail author
Article

Abstract

Aims/hypothesis

The determination of diabetes as underlying cause of death by using the death certificate may result in inaccurate estimation of national mortality attributed to diabetes, because individuals who die with diabetes generally have other conditions that may contribute to their death. We investigated the trends in age-standardised mortality due to diabetes as underlying or contributing cause of death and cause-specific mortality from cardiovascular disease (CVD), complications of diabetes and cancer among individuals with diabetes listed on death certificates in the USA from 2007 to 2017.

Methods

Using the US Census and national mortality database, we calculated age-standardised mortality due to diabetes as underlying or contributing cause of death and cause-specific mortality rates among adults over 20 years with diabetes listed on death certificates. A total of 2,686,590 deaths where diabetes was underlying or contributing cause of death were analysed. We determined temporal mortality rate patterns by joinpoint regression analysis with estimates of annual percentage change (APC).

Results

Age-standardised diabetes mortality rates compared among underlying cause of death, contributing cause of death and all-cause mortality were 32.2 vs 75.7 vs 105.1 per 100,000 individuals during the study period. The age-standardised mortality rates due to diabetes as underlying or contributing cause of death declined from 112.2 per 100,000 individuals in 2007 to 104.3 per 100,000 individuals in 2017 with the most pronounced decline noted from 2007 to 2014 (APC −1.4%; 95% CI −1.9%, −1.0%) and stabilisation in decline from 2014 to 2017 (APC 1.1%; 95% CI −0.6%, 2.8%). In terms of cause-specific mortality among individuals with diabetes listed on death certificates, the age-standardised mortality rates for CVD declined at an annual rate of 1.2% with a marked decline of 2.3% between 2007 and 2014. Age-standardised diabetes-specific mortality rates as underlying cause of death decreased from 2007 to 2009 (APC −4.5%) and remained stable from 2009 to 2017. Age-standardised mortality rates for cancer steadily decreased with an average APC of −1.4% (95% CI −1.8%, −1.0%) during the 11-year period. Mortality in the subcategory of CVD demonstrated significant differences.

Conclusions/interpretation

Current national estimates capture about 30% of all-cause mortality among individuals with diabetes listed as underlying or contributing cause of death on death certificates. The age-standardised mortality due to diabetes as underlying or contributing cause of death and cause-specific mortality from CVD in individuals with diabetes listed as underlying or contributing cause of death plateaued from 2014 onwards except for hypertensive heart disease and heart failure.

Keywords

Cancer Cardiovascular disease Complication Epidemiology Mortality 

Abbreviations

APC

Annual percentage change

CeVD

Cerebrovascular disease

CVD

Cardiovascular disease

HF

Heart failure

HHD

Hypertensive heart disease

IHD

Ischaemic heart disease

NHIS

National Health Interview Survey

NVSS

National Vital Statistics System

Notes

Contribution statement

DK was responsible for study concept and design, acquisition of data, statistical analysis, interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content and approval of the final draft manuscript. AAL, GC, SHK, EI, JWK and RAH were responsible for study concept and design, analysis and interpretation of data, critical revision of the manuscript for important intellectual content and statistical analysis, and approval of the final draft manuscript. AA was responsible for study concept and design, analysis and interpretation of data, critical revision of the manuscript for important intellectual content, approval of final draft manuscript and supervision of the research project. AA is responsible for the integrity of the work as a whole.

Funding

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. JWK was supported by the National Institutes of Health, USA (P30DK116074, U41HG009649, 1R01DK107437).

Duality of interest

The authors declare that there is no duality of interest associated with this manuscript.

References

  1. 1.
    NCD Risk Factor Collaboration (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387:1513–1530CrossRefGoogle Scholar
  2. 2.
    Cowie CC, Rust KF, Byrd-Holt DD et al (2006) Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care 29(6):1263–1268.  https://doi.org/10.2337/dc06-0062 CrossRefPubMedGoogle Scholar
  3. 3.
    Geiss LS, Wang J, Cheng YJ et al (2014) Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA 312(12):1218–1226.  https://doi.org/10.1001/jama.2014.11494 CrossRefPubMedGoogle Scholar
  4. 4.
    CDC NDSS (2015) National Diabetes Statistics Report. Available from https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed 10 January 2018
  5. 5.
    IDF Diabetes Atlas Group (2015) Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2013. Diabetes Res Clin Pract 109(3):461–465.  https://doi.org/10.1016/j.diabres.2015.05.037 CrossRefPubMedGoogle Scholar
  6. 6.
    Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095–2128.  https://doi.org/10.1016/S0140-6736(12)61728-0 CrossRefPubMedGoogle Scholar
  7. 7.
    Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E (2017) Deaths: final data for 2015. Natl Vital Stat Rep 66:1–75PubMedGoogle Scholar
  8. 8.
    Hunt BR, Whitman S, Henry CA (2014) Age-adjusted diabetes mortality rates vary in local communities in a metropolitan area: racial and spatial disparities and correlates. Diabetes Care 37(5):1279–1286.  https://doi.org/10.2337/dc13-0988 CrossRefPubMedGoogle Scholar
  9. 9.
    Stokes A, Preston SH (2017) Deaths attributable to diabetes in the United States: comparison of data sources and estimation approaches. PLoS One 12(1):e0170219.  https://doi.org/10.1371/journal.pone.0170219 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tancredi M, Rosengren A, Svensson AM et al (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373(18):1720–1732.  https://doi.org/10.1056/NEJMoa1504347 CrossRefPubMedGoogle Scholar
  11. 11.
    Saydah SH, Geiss LS, Tierney E, Benjamin SM, Engelgau M, Brancati F (2004) Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Ann Epidemiol 14(7):507–516.  https://doi.org/10.1016/j.annepidem.2003.09.016 CrossRefPubMedGoogle Scholar
  12. 12.
    Zhang X, Geiss LS, Cheng YJ, Beckles GL, Gregg EW, Kahn HS (2008) The missed patient with diabetes: how access to health care affects the detection of diabetes. Diabetes Care 31(9):1748–1753.  https://doi.org/10.2337/dc08-0527 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Fedeli U, Zoppini G, Goldoni CA, Avossa F, Mastrangelo G, Saugo M (2015) Multiple causes of death analysis of chronic diseases: the example of diabetes. Popul Health Metrics 13(1):21.  https://doi.org/10.1186/s12963-015-0056-y CrossRefGoogle Scholar
  14. 14.
    Global Burden of Cardiovascular Diseases Collaboration, Roth GA, Johnson CO et al (2018) The burden of cardiovascular diseases among US states, 1990-2016. JAMA Cardiol 3(5):375–389.  https://doi.org/10.1001/jamacardio.2018.0385 CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Rodriguez F, Hastings KG, Boothroyd DB et al (2017) Disaggregation of cause-specific cardiovascular disease mortality among hispanic subgroups. JAMA Cardiol 2(3):240–247.  https://doi.org/10.1001/jamacardio.2016.4653 CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Lind M, Garcia-Rodriguez LA, Booth GL et al (2013) Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia 56(12):2601–2608.  https://doi.org/10.1007/s00125-013-3063-1 CrossRefPubMedGoogle Scholar
  17. 17.
    Ford ES (2011) Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: findings from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes Care 34(6):1337–1343.  https://doi.org/10.2337/dc10-2251 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Thomas RJ, Palumbo PJ, Melton LJ 3rd et al (2003) Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med 163(4):445–451.  https://doi.org/10.1001/archinte.163.4.445 CrossRefPubMedGoogle Scholar
  19. 19.
    Rawshani A, Rawshani A, Franzen S et al (2017) Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 376(15):1407–1418.  https://doi.org/10.1056/NEJMoa1608664 CrossRefPubMedGoogle Scholar
  20. 20.
    Bureau USC (2017) The nation’s older population is still growing, Census Bureau reports. Available at https://www.census.gov/newsroom/press-releases/2017/cb17-100.html. Accessed 10 January 2018
  21. 21.
    Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD (2012) The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 156(4):271–278.  https://doi.org/10.7326/0003-4819-156-4-201202210-00004 CrossRefPubMedGoogle Scholar
  22. 22.
    Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351.  https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z CrossRefPubMedGoogle Scholar
  23. 23.
    Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK (2009) Estimating average annual per cent change in trend analysis. Stat Med 28(29):3670–3682.  https://doi.org/10.1002/sim.3733 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Gregg EW, Cheng YJ, Saydah S et al (2012) Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 35(6):1252–1257.  https://doi.org/10.2337/dc11-1162 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC (2007) Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 147(3):149–155.  https://doi.org/10.7326/0003-4819-147-3-200708070-00167 CrossRefPubMedGoogle Scholar
  26. 26.
    Preis SR, Hwang SJ, Coady S et al (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 119(13):1728–1735.  https://doi.org/10.1161/CIRCULATIONAHA.108.829176 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Gregg EW, Cheng YJ, Srinivasan M et al (2018) Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 391(10138):2430–2440.  https://doi.org/10.1016/S0140-6736(18)30314-3 CrossRefPubMedGoogle Scholar
  28. 28.
    Bennett PH (2018) Diabetes mortality in the USA: winning the battle but not the war? Lancet 391(10138):2392–2393.  https://doi.org/10.1016/S0140-6736(18)30843-2 CrossRefPubMedGoogle Scholar
  29. 29.
    Cheng YJ, Imperatore G, Geiss LS et al (2018) Trends and disparities in cardiovascular mortality among U.S. adults with and without self-reported diabetes, 1988-2015. Diabetes Care 41(11):2306–2315.  https://doi.org/10.2337/dc18-0831 CrossRefPubMedGoogle Scholar
  30. 30.
    Ford ES, Ajani UA, Croft JB et al (2007) Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 356(23):2388–2398.  https://doi.org/10.1056/NEJMsa053935 CrossRefPubMedGoogle Scholar
  31. 31.
    Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF (2010) Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics 8(1):29.  https://doi.org/10.1186/1478-7954-8-29 CrossRefGoogle Scholar
  32. 32.
    Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K, Steering Group of the National Diabetes Register (2008) The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 51(12):2187–2196.  https://doi.org/10.1007/s00125-008-1156-z CrossRefPubMedGoogle Scholar
  33. 33.
    Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW (2013) Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 368(17):1613–1624.  https://doi.org/10.1056/NEJMsa1213829 CrossRefPubMedGoogle Scholar
  34. 34.
    Wang J, Geiss LS, Cheng YJ et al (2011) Long-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988–2008. Diabetes Care 34(7):1579–1581.  https://doi.org/10.2337/dc11-0178 CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Rawshani A, Rawshani A, Franzen S et al (2017) Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus. Circulation 135(16):1522–1531.  https://doi.org/10.1161/CIRCULATIONAHA.116.025961 CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM (2012) Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care 35(9):1835–1844.  https://doi.org/10.2337/dc12-0002 CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Harding JL, Shaw JE, Peeters A, Guiver T, Davidson S, Magliano DJ (2014) Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997-2010. Diabetes Care 37(9):2579–2586.  https://doi.org/10.2337/dc14-0096 CrossRefPubMedGoogle Scholar
  38. 38.
    Heron M (2017) Deaths: leading causes for 2015. Natl Vital Stat Rep 66:1–76PubMedGoogle Scholar
  39. 39.
    Lloyd-Jones DM, Martin DO, Larson MG, Levy D (1998) Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 129(12):1020–1026.  https://doi.org/10.7326/0003-4819-129-12-199812150-00005 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Donghee Kim
    • 1
  • Andrew A. Li
    • 2
  • George Cholankeril
    • 1
  • Sun H. Kim
    • 3
  • Erik Ingelsson
    • 4
    • 5
  • Joshua W. Knowles
    • 4
    • 5
  • Robert A. Harrington
    • 2
  • Aijaz Ahmed
    • 1
    • 5
    Email author
  1. 1.Division of Gastroenterology and HepatologyStanford University School of MedicinePalo AltoUSA
  2. 2.Department of MedicineStanford University School of MedicineStanfordUSA
  3. 3.Division of Endocrinology, Gerontology and MetabolismStanford University School of MedicineStanfordUSA
  4. 4.Cardiovascular Medicine and Cardiovascular InstituteStanford University School of MedicineStanfordUSA
  5. 5.Stanford Diabetes Research CenterStanford University School of MedicineStanfordUSA

Personalised recommendations